Kasatori Noriko, Ishikawa Fumio, Ueyama Mamoru, Urayama Tsutomu
Department of Laboratory Medicine, Toho University School of Medicine, Ota-ku, Tokyo, Japan.
J Immunol Methods. 2005 Dec 20;307(1-2):41-53. doi: 10.1016/j.jim.2005.09.005. Epub 2005 Oct 11.
Annexin V and propidium iodide (PI) staining is a general technique for detecting apoptosis by flow-cytometry (FCM). The release of 2',7'-bis-(2-carboxyethyl)-5- (and-6)-carboxyfluorescein (BCECF), a non-lipophilic membrane-impermeable labeling dye, from the cytoplasm of target cells is an indicator of increased membrane permeability. This study aimed to devise a three-color FCM technique involving the BCECF-release parameter in addition to conventional Annexin V and PI staining for the analysis of target K562 cells undergoing cytotoxic/apoptotic processes mediated by natural killer (NK) cells. The results demonstrated the following step-wise process of membrane impairment: (1) initiation of Annexin V staining accompanied by increasing forward scatter (FSC) before BCECF-release, indicating membrane impairment without permeabilization by necrosis; (2) BCECF-release with decreasing FSC before PI influx; and (3) PI staining with the lowest FSC state. Therefore, the early stage of cytotoxicity/apoptosis conventionally defined by the flow-cytometric criteria of Annexin V staining before PI staining could be sub-divided into two stages before and after BCECF-release. Annexin-V staining in tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis was also initiated without BCECF-release. Although the underlying mechanism of the transition process from stage 1 to stage 2 is still unknown, this FCM technique should be a useful tool for differential assays of target cells regarding the sequential processes of NK-induced cytotoxicity.
膜联蛋白V和碘化丙啶(PI)染色是通过流式细胞术(FCM)检测细胞凋亡的常用技术。2',7'-双(2-羧乙基)-5-(和-6)-羧基荧光素(BCECF)是一种非亲脂性的膜不透性标记染料,其从靶细胞胞质中的释放是膜通透性增加的指标。本研究旨在设计一种三色FCM技术,除了传统的膜联蛋白V和PI染色外,还涉及BCECF释放参数,用于分析经历自然杀伤(NK)细胞介导的细胞毒性/凋亡过程的靶K562细胞。结果表明了膜损伤的以下逐步过程:(1)在BCECF释放之前,膜联蛋白V染色开始,同时前向散射(FSC)增加,表明膜损伤但未因坏死而通透;(2)在PI流入之前,BCECF释放且FSC降低;(3)在最低FSC状态下进行PI染色。因此,传统上由PI染色之前膜联蛋白V染色的流式细胞术标准定义的细胞毒性/凋亡早期阶段可细分为BCECF释放之前和之后的两个阶段。肿瘤坏死因子相关凋亡诱导配体(TRAIL)诱导的凋亡中的膜联蛋白V染色也在没有BCECF释放的情况下开始。虽然从第1阶段到第2阶段转变过程的潜在机制仍然未知,但这种FCM技术应该是用于对靶细胞关于NK诱导的细胞毒性的连续过程进行差异分析的有用工具。